Bronchopulmonary Dysplasia Market
Jul 25, 2022
Exploring Potential New Avenues for Bronchopulmonary Dysplasia Treatment
Bronchopulmonary Dysplasia is the most common long-term respiratory morbidity of low-weight or premature infants, with the risk of development proportional to the degree of prematurity. It is also referred to as chronic lung disease of premature babies. It is a chronic respiratory disease that often occurs in low-w...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
